Committees to monitor the accumulating data from the clinical trials. Such committees have chief responsibilities for ensuring the continuing safety of the trial participants, relevance of the trial query, suitability of the treatment protocol and the integrity and quality of the accumulating data. The committees must be multidisciplinary, and should for all time include individuals with the relevant clinical and statistical expertise.